Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial

	Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
	Lu, S.2; Jian, H.2; Zhang, Y.3; Song, Z.3; Zhao, Y.4; Wang, P.5; Jiang, L.2; Gong, Y.1; Zhou, J.6; Dong, X.7
刊名	JOURNAL OF THORACIC ONCOLOGY
	2022-09-01
卷号	17
关键词	Non-small cell lung cancer KRAS G12C mutation Small molecular inhibitor
ISSN号	1556-0864
WOS研究方向	Oncology ; Respiratory System
语种	英语
出版者	ELSEVIER SCIENCE INC
WOS记录号	WOS:000858678100017
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129929]
专题	中国科学院合肥物质科学研究院
作者单位	1.Chongqing Univ, Chongqing Canc Hosp, Canc Hosp, Chongqing, Peoples R China 2.Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 4.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China 5.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China 6.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China 7.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Changsha, Peoples R China 8.Hunan Canc Hosp, Changsha, Peoples R China 9.Beijing Canc Hosp, Beijing, Peoples R China 10.Fujian Prov Canc Hosp, Fuzhou, Peoples R China
推荐引用方式 GB/T 7714	Lu, S.,Jian, H.,Zhang, Y.,et al. Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17.
APA	Lu, S..,Jian, H..,Zhang, Y..,Song, Z..,Zhao, Y..,...&Wang, Y..(2022).Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial.JOURNAL OF THORACIC ONCOLOGY,17.
MLA	Lu, S.,et al."Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial".JOURNAL OF THORACIC ONCOLOGY 17(2022).